This content is machine translated Stroke Secondary Prevention Ticagrelor as add-on leads to significant risk reduction Results from the Phase III THALES trial show that ticagrelor, when taken concomitantly with aspirin, produces a statistically significant and clinically meaningful reduction in stroke recurrences compared with aspirin treatment…
